Operating Income (Loss) of Regenerative Medical Technology Group Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Regenerative Medical Technology Group Inc. quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
Regenerative Medical Technology Group Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $445,761, a 2369% decline year-over-year.
Regenerative Medical Technology Group Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $180,268.
Regenerative Medical Technology Group Inc. annual Operating Income (Loss) for 2024 was $81,181.
Source SEC data: View on sec.gov

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Change (%)

Operating Income (Loss), Annual (USD)

Regenerative Medical Technology Group Inc. Quarterly Operating Income (Loss) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$180,268	$445,761	-$465,409	-2369%	01 Jul 2025	30 Sep 2025	10-Q	19 Nov 2025	2025	Q3
Q2 2025	$285,141	$250,086	-$36,105	-17%	01 Apr 2025	30 Jun 2025	10-Q	19 Aug 2025	2025	Q2
Q1 2025	$321,246	$134,960	+$240,065		01 Jan 2025	31 Mar 2025	10-Q	20 May 2025	2025	Q1
Q4 2024	$81,181	$380,619			01 Oct 2024	31 Dec 2024	10-K	15 Apr 2025	2024	FY
Q3 2024		$19,648			01 Jul 2024	30 Sep 2024	10-Q	19 Nov 2025	2025	Q3
Q2 2024		$213,981			01 Apr 2024	30 Jun 2024	10-Q	19 Aug 2025	2025	Q2
Q1 2024		$105,105			01 Jan 2024	31 Mar 2024	10-Q	20 May 2025	2025	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$81,181	+$796,407		01 Jan 2024	31 Dec 2024	10-K	15 Apr 2025	2024	FY
2023	$715,226			01 Jan 2023	31 Dec 2023	10-K	15 Apr 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.